Decreased warfarin effects in elder with recurrent Clostridium difficile infection during fidaxomicin therapy: a case report
Clostridium difficile infection is a disease with increasing incidence, particularly in high‑riskpatients such as the elderly, immunocompromised patients, etc. We report an unexpected decrease of International Normalized Ratio (INR) response to warfarin during a first recurrence of Clostridium diff...
Main Authors: | Antonio Riccardo Buonuomo, Maria Alessandra Foggia, Emanuela Zappulo, Guglielmo Borgia, Ivan Gentile |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd
2015-03-01
|
Series: | Clinical Management Issues |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/953 |
Similar Items
-
Fidaxomicin in the treatment of colitis due to Clostridium difficile: preliminary results
by: Francesco Cortese, et al.
Published: (2014-12-01) -
Toxic megacolon associated with Clostridium difficile infection recurrence: a case report complicated by multiple bacterial infections and successfully treated with oral fidaxomicin
by: Addolorata Masiello, et al.
Published: (2014-12-01) -
Recurrent Clostridium difficile colitis in elderly: the role of fidaxomicin
by: Francesco Artom, et al.
Published: (2014-12-01) -
High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China
by: Jing-Wei Cheng, et al.
Published: (2018-06-01) -
Fidaxomicin - the new drug for Clostridium difficile infection
by: Chetana Vaishnavi
Published: (2015-01-01)